Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Hub
News
Changes
Search
Log in
Get Started
QLOSI (PILOCARPINE HYDROCHLORIDE) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
QLOSI
NDA
Get alerts
PILOCARPINE HYDROCHLORIDE | N217836 | ORASIS PHARMACEUTICALS LTD
1 strength
4 unique patents
1 unique exclusivity
Patents
SEC Intel
Revenue
PTAB
Reexams
Litigation
Petitions
Trials
DMF
Approvals
Label
Products
Patent Timeline
4 unique patents, 1 exclusivity by expiration date
Active (4)
Today
Exclusivity
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
Today
9867810
Aug. 18, 2037
10639297
Aug. 18, 2037
11129812
Aug. 18, 2037
11974986
Aug. 18, 2037
NP
Oct. 17, 2026
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — 0.4%
RLD
4 patents
1 exclusivity
▴
SOLUTION/DROPS;OPHTHALMIC | Approved: Oct 17, 2023
Patents (4)
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
9867810
Aug 18, 2037
—
—
Yes
U-3741
TREATMENT OF PRESBYOPIA
—
10639297
Aug 18, 2037
—
—
Yes
U-3741
TREATMENT OF PRESBYOPIA
—
11129812
Aug 18, 2037
—
—
—
U-3741
TREATMENT OF PRESBYOPIA
—
11974986
Aug 18, 2037
—
—
—
U-3741
TREATMENT OF PRESBYOPIA
—
Exclusivities (1)
Code
Date
Status
NP
Oct 17, 2026
< 1 year